Rhythm Stick has come a long way in a short time, and with a small vineyard. It is owned by Ron and Jeanette Ely, who in 1997 purchased a 3.2ha property at Penwortham. The couple had already decided ...

Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Rhythm Pharmaceuticals (RYTM – Research Report) today and set a price target of $78.00. The company’s shares opened today at $47.95.